Xact Kapitalforvaltning’s Array Biopharma Inc ARRY Stock Holding History

Xact Kapitalforvaltning’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-36,278	Closed	-$1.68M	–	1457
2019 Q2	$1.68M	Hold	36,278	–	–	0.03%	412
2019 Q1	$884K	Hold	36,278	–	–	0.02%	629
2018 Q4	$517K	Buy	36,278 +3,100	+9%	+$47K	0.01%	859
2018 Q3	$504K	Buy	33,178 +2,900	+10%	+$44.4K	0.01%	964
2018 Q2	$508K	Buy	30,278 +4,500	+17%	+$71.6K	0.01%	926
2018 Q1	$421K	Buy	25,778 +7,300	+40%	+$117K	0.01%	954
2017 Q4	$237K	Buy	+18,478	New	+$210K	0.01%	1124

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Xact Kapitalforvaltning's ARRY Position: Q3 2019 in Review

Xact Kapitalforvaltning sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 36,278 shares — an estimated $1.68M sold.

Xact Kapitalforvaltning first reported a position in ARRY in Q4 2017 and held it in 7 quarters. The position peaked at $1.68M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Xact Kapitalforvaltning reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Xact Kapitalforvaltning sold 36,278 Array Biopharma Inc shares in Q3 2019, an estimated $1.68M.
Xact Kapitalforvaltning first reported a position in Array Biopharma Inc in Q4 2017 and held it in 7 quarters.
Xact Kapitalforvaltning's Array Biopharma Inc position peaked at $1.68M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Xact Kapitalforvaltning's 13F filing for Q3 2019, filed 31 Oct 2019.